Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
Infectious Diseases and Therapy - United States
doi 10.1007/s40121-017-0184-8
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2018
Authors
Publisher
Springer Science and Business Media LLC